Search results for

Elizabeth Rhodus’s past experiences as an occupational therapist, and a motivation to enhance clinical care, led her to develop the innovative intervention now known as Harmony at H.O.M.E., which emphasizes sensory-based techniques in the home environment for those living with dementia. She talks about the technique in this week’s edition of Dr. Greg Davis on Medicine.

The University of Kentucky is home to a new center that will advance research on the medical use of cannabis. The center will conduct research on the health effects of cannabis, including its risks and benefits when used to treat certain medical conditions. Dr. Greg speaks with UK Cannabis Center director Shanna Babalonis.

Stigma and discrimination against people with substance use disorders (SUD) have directly contributed to Kentucky’s addiction crisis. Now, Kentuckians who have been personally impacted by substance use disorder will take center stage in a stigma reduction campaign that launched this spring. Dr. Greg talks with Asha Carroll, Director of Social Media Engagement for the media group, Shatterproof which is spearheading the effort.

While the arrival of summer can be exciting, it also ushers in what the medical community calls “trauma season” when warm weather and increase in outdoor activities results in a higher number of unintentional injuries requiring emergency care. As many of these injuries are potentially life-threatening, there is also an increase in the need for blood transfusions, so keeping up the blood supply becomes even more important. This week Dr. Greg talks about summer blood drives with Morgan H. McCoy, assistant professor of pathology and laboratory medicine at the UK College of Medicine.

As people in eastern Kentucky try to piece back together their lives following deadly floods, many may ignore warning signs and symptoms of trauma and PTSD. This week Dr. Greg talks about the mental health component of disaster cleanup with UK HealthCare’s Gray Manis; licensed clinical social worker and assistant professor of psychiatry.

September is National Recovery Month and we're revisiting a conversation with Asha Carroll, Director of Social Media Engagement for the media group, Shatterproof which is spearheading an effort to de-stigmatize substance use disorders in the commonwealth. The project is called UNShame Kentucky.

With the recent discovery of the polio virus in the water supply in New York state, how worried should Kentuckians be of a possible new outbreak of a disease long thought eradicated? Dr. Greg talks polio and vaccination with Ilhem Messaoudi, Ph.D., a UK College of Medicine immunology and virology expert who serves as chair of the Department of Microbiology, Immunology, and Molecular Genetics.

The World Health Organization recently declared monkeypox a public health emergency of international concern as the virus is now spreading throughout North America and Europe where it is not usually found. Lexington confirmed its first case of monkeypox on August 17th. While the risk for Kentuckians remains relatively low, everyone should be vigilant. Fortunately, there are steps you can take to protect yourself and limit the spread. Dr. Greg gets the lowdown from Ilhem Messaoudi, Ph.D., a UK College of Medicine immunology and virology expert who serves as chair of the Department of Microbiology, Immunology, and Molecular Genetics.

As of Monday September 12th new bivalent Covid vaccines are available for people who meet certain criteria. This week on Dr. Greg Davis on Medicine, we get the scoop from Vince Venditto, assistant professor, Department of Pharmaceutical Sciences in the UK College of Pharmacy.

Findings from a new University of Kentucky College of Medicine study published in the Journal of Biological Chemistry May 28 may lead to a new treatment against Toxoplasma gondii, the parasite that causes toxoplasmosis. The labs of Matthew Gentry, Ph.D., and Craig Vander Kooi, Ph.D., in the Department of Molecular and Cellular Biochemistry, Anthony Sinai, Ph.D., in the Department of Microbiology, Immunology and Molecular Genetics, and Zhong-Yin Zhang, Ph.D., at the Purdue Institute for Drug Discovery, collaborated to develop a drug that targets the cyst form of the parasite. Dr. Greg talks with Gentry about the breakthrough research.